Advances in global health (1888PressRelease) highlights the benefits of the investment, including improving access to medicines and economic growth.
Washington, DC-MD-VA-WV - a recent fact sheet for global health progress highlights how investment in the biopharmaceutical sector Mexico stimulated economic growth, enhanced competitiveness, reduced health and economic citizens for a better access to the médicaments.Avec disease burden the tenth largest economy in the world, Mexico invests over 1% of its GDP in the biopharmaceutical sector and this percentage is expected that the country strives to develop drugs of tomorrow.
Like the United States and other major emerging markets, Mexico recognized the potential of the biopharmaceutical sector to be an important source of economic growth through the creation of quality jobs, highly qualified.Currently, the Mexico biopharmaceutical sector employs nearly 25,000 Mexican nationals over 32 companies biotechnologie.Le number of skilled workers in the labour force is predicted to increase in more than 750 000 engineering and technology students at the Mexico are currently enrolled at local universities. In addition, the collaboration between the public and the private sector enabled the creation of over 100 research centres.
Emphasis on job creation Mexico stimulates the development of new drugs, thereby improving access to medicines for all citizens. For example, there are approximately 254 drug development or pending regulatory review for Mexican and Mexico patients currently 19 25 in terms of active clinical trial sites.Growth on the part of the global clinical trial sites can provide health benefits in Mexican patients, such as the diffusion of medical knowledge, more patience access to medicines and healthcare quality and effective medical practice.
Recognizing the potential for economic growth, improve access to medicines and inspire innovative drugs, the Mexican Government has sought to implement policies aimed at promoting the growth of the secteur.Le National Council of science and technology, Government of main body Mexico, research funding provided approximately 16 million to fund projects between 2001 basic science and 2004.Mexique has also several clusters, consisting of the biotechnology and biopharmaceutical companies, focused on the pharmaceutical R & d.In addition, public-private partnerships between the Government of the Mexico, universities and industry are increasing partly to the continued commitment of Government science and technology research and education.
Please see the complete PDF for further information and the list of sources.
On global Health Progress:
Global Health Progress also supports efforts to raise awareness and mobilize resources to meet the challenges of health in the developing world by providing local leaders as well as international health experts, policymakers, donor Governments and sector privé.www.globalhealthprogress.org Twitter.com English.PDF Facebook.com/Group.php?GID=35156473766; LinkedIn.com groups? gid = 2972068 & home =
To stay informed on the latest news about global investment in pharmaceutical research and improve access to medicines, sign up to receive special alerts and newsletters purposesyou can also spread to the efforts of the Global Health Progress initiative and retain other informed of how we are influencing changes in the world, or share your story on how you or someone you know is working to promote global health.
Visit http://www.GlobalHealthProgress.org for more details and information.
Source:
http://www.1888pressrelease.com/fact-sheet-reveals-Mexico-s-increasing-Investment-in-biophar-PR-250930.html
This entry transmitted via the service for full-text RSS - if this is your content and you read on someone to another site, please read our FAQ page fivefilters.org/content-only/faq.php
Article five filters features: After Hiroshima - non-rapport Cancer Catastrophe of Fallujah.
No comments:
Post a Comment